Skip to search formSkip to main contentSkip to account menu

Vincristine sulfate liposome

Known as: vincristine sulfate liposomes 
A sphingomyelin/cholesterol liposomal formulation of vincristine sulfate with potential antineoplastic activity. Vincristine, a vinca alkaloid… 
National Institutes of Health

Related topics

Related topics

8 relations

Narrower (2)

MarqiboOnco TCS
Microtubule ProcessMicrotubulesNegative Regulation of MitosisTubulin

Broader (2)

Vincristine Sulfatevincristine liposome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Nanocarriers as Magic Bullets in the Treatment of Leukemia
Leukemia is a type of hematopoietic stem/progenitor cell malignancy characterized by the accumulation of immature cells in the… 
2018
2018
Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
Objective: This phase Ia study was designed to assess the pharmacokinetic (PK) characters of free vincristine (F-VCR, refer to as… 
Highly Cited
2016
Highly Cited
2016
Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias
Vincristine sulfate liposome injection (VSLI; Marqibo®) is an encapsulated preparation of standard vincristine in sphingomyelin… 
2016
2016
The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
Purpose This study was designed to improve the in vivo pharmacokinetics of long-circulating vincristine sulfate (VS)-loaded… 
2013
2013
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non‐liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or…
Vincristine sulfate liposome injection (VSLI; Marqibo®; M) is active in relapsed and refractory lymphomas, and approved in the… 
2013
2013
Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia
Vincristine sulfate liposome injection (VSLI,) is a sphingomyelin and cholesterol nanoparticle formulation of vincristine sulfate… 
2012
2012
Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumors
Aim:To evaluate the single- and multiple-dose pharmacokinetics of vincristine sulfate liposomes (VSLI) in patients with advanced… 
Highly Cited
2009
Highly Cited
2009
Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia
Dose intensification of chemotherapy has improved outcome for younger adults with de novo acute lymphoblastic leukemia (ALL… 
Highly Cited
2006
Highly Cited
2006
Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients
Vincristine sulfate liposomes injection (VSLI) is a liposomal formulation of vincristine encapsulated in sphingosomes composed of… 
1998
1998
Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection
Abstract The pharmacokinetic behavior of vincristine sulfate (VINC) following administration of vincristine sulfate liposome… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)